NCT06545253View on ClinicalTrials.gov

A New Diagnostic Paradigm for Retinitis Pigmentosa Secondary to USH2A Pathogenic Variants

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2027

Conditions
USH2A Variant Retinitis Pigmentosa
Interventions
DIAGNOSTIC_TEST

microRNAs analysis

Patients will undergo routinary ophthalmological examination, multimodal retinal imaging and blood sampling

All Listed Sponsors
lead

IRCCS Ospedale San Raffaele

OTHER

NCT06545253 - A New Diagnostic Paradigm for Retinitis Pigmentosa Secondary to USH2A Pathogenic Variants | Biotech Hunter | Biotech Hunter